We have located links that may give you full text access.
Mannopyranoside Glycolipids Inhibit Mycobacterial Growth, Biofilm and Potentiate Isoniazid Inhibition Activities in M. smegmatis.
Chembiochem : a European Journal of Chemical Biology 2019 April 6
Lipomannan and lipoarabinomannan are integral components of mycobacterial cell wall. Our earlier studies demonstrated that synthetic arabinan and arabinomannan glycolipids act as inhibitors of mycobacterial growth, in addition to exhibiting inhibitory activities of mycobacterial biofilm. In the present study, we demonstrate that synthetic mannan glycolipids are better inhibitors of the mycobacterial growth, whereas, lipoarabinomannan has higher inhibition efficiencies to biofilm. Syntheses of mannan glycolipids with graded number of mannan moieties and an arabinomannan glycolipid are conducted by chemical methods and subsequent mycobacterial growth and biofilm inhibition studies are conducted on M. smegmatis. Growth inhibition of 73 ± 3% is observed with a mannose trisaccharide containing glycolipid, whereas this glycolipid did not promote biofilm inhibition activity better than arabinomannan glycolipid. The antibiotic supplementation activities of glycolipids on growth and biofilm inhibitions are evaluated. Fold increases in the growth and biofilm inhibitions are observed when the antibiotic is supplemented with glycolipids, leading to a significant reduction of inhibition concentrations of the antibiotic.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app